logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
arrow
Back
N

Neurocrine Biosciences

Scholars294
Papers104
Citations0
Related Papers (17)
Publication Date
delete
Corrigendum to “exploratory anchor-based analyses to determine minimal clinically important differences for the brief assessment of cognition in schizophrenia and the schizophrenia cognition rating scale” [Schizophr. Res. 2026 July 25. doi:10.1016/j.schres.2026.07.021. Epub ahead of print]
errSchizophrenia Research
IF3.5
err2026-08-18
err0
PREAI
errHans S. Klein; Reuben H. Fan; Tingting Ge; Mahnaz Asgharnejad; Chris Brady; Elizabeth Hanson; Philip D. Harvey; Jan Sedway; Venkatesha Murthy; Richard S.E. Keefe; Jaskaran B. Singh; Ni A. Khin
errShare
errSave
F39. THE PATIENT-REPORTED TARDIVE DYSKINESIA IMPACT SCALE (TDIS) IN PATIENTS ≥65 YEARS TREATED WITH ONCE-DAILY VALBENAZINE: FINDINGS FROM KINECT-PRO™
errAmerican Journal of Geriatric Psychiatry
IF3.8
err2026-08-14
err0
PREAI
errM. Mercedes Perez-Rodriguez; Joseph McEvoy; Ashok Parameswaran; Morgan Bron; Sara Gao; Sharon Cahoon-Metzger; Christine Holman; Susan D. Mathias; Gustavo Alva; Christoph U. Correll
errShare
errSave
Linking clinical trial data with real-world data for enhanced clinical evidence generation: methodological considerations and recommendations
errFrontiers in Pharmacology
IF4.8
err2026-08-14
err0
errOAAI
errAM Anna-Katharina Meinecke †; JD John Diaz-Decaro †; KM Kathleen M. Gavin; TS Tianyu Sun; JB Jordan B. Strom; MS Montse Soriano Gabarró; HL Hu Li; DY Dana Y. Teltsch; MN Mehdi Najafzadeh; CA Catherine A. Panozzo; PV Pareen Vora; MB Mehmet Burcu †
errShare
errSave
Glucocorticoid Reduction After Starting Crinecerfont in Pediatric Patients With Classic CAH: Practical Perspectives
errThe Journal of Clinical Endocrinology and Metabolism
IF0
err2026-08-01
err0
errOAAI
errNatalie J Nokoff; Patricia Y Fechner; Mimi S Kim; Ian Marshall; Deborah P Merke; Kyriakie Sarafoglou; Andrea L Hartzell; Vivian H Lin; Paul Thornton
errShare
errSave
Effectiveness and safety of implantable vagus nerve stimulation in people with primary generalized tonic-clonic seizures
errEpilepsia Open
IF2.9
err2026-05-01
err0
errOAAI
errEggleston, Katherine; Curley, Justine; Verner, Ryan; Dibue, Maxine; Gordon, Charles; Giannicola, Gaia; Nichol, Kathryn
errShare
errSave
Opicapone Improves the Pharmacokinetics of Levodopa Administered as Extended-Release Capsules
errClinical Neuropharmacology
IF1.5
err2026-05-01
err0
PREAI
errLeWitt, Peter A.; Klepitskaya, Olga; Olson, Kurt; Liang, Grace; Loewen, Gordon
errShare
errSave
Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study
errClinical Parkinsonism & Related Disorders
IF1.8
err2026-01-01
err0
errOAAI
errKlepitskaya, Olga; LeWitt, Peter A.; Kilbane, Camilla; Seeberger, Lauren C.; Isaacson, Stuart H.; Gil, Ramon; Drake, Ryan S.; Kleiner, Galit; Stebbins, Glenn T.; Serbin, Michael; Brigas, Helena C.; Ramos, Daniel; Rattana, Stacy; Trotter, Jeff; Liang, Grace
errShare
errSave
Evaluating the psychometric properties of HIV/AIDS stigma among postgraduate medical students in Southern India: a Rasch analysis approach
errHealth Services and Outcomes Research Methodology
IF1.6
err2026-01-01
err0
errOAAI
errGoswami, Swarnali; Borate, Samruddhi Nandkumar; Marupuru, Sumanth; Marupuru, Srujitha
errShare
errSave
Use of new approach methodologies (NAMs) in epilepsy research and seizure risk assessment
errDrug Discovery Today
IF7.5
err2025-12-03
err0
errOAAI
errRuth A. Roberts; Mamta Behl; Helena T. Hogberg; Eduardo Dunayevich; Micheal Morton; Kimberly Rockley; Abigail L Walker; Jennifer Pierson
errShare
errSave
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
errThe Lancet Psychiatry
IF0
err2025-11-11
err0
PREAI
errRichard S E Keefe; Philip D Harvey; Christoph U Correll; Peter Falkai; Naoki Hashimoto; Hans Klein; John H Krystal; Stephen Marder; Alice Medalia; Tomiki Sumiyoshi; Gang Wang; Hongyan Zhang; Zuzana Blahova; Ingrid Bichard-Sall; Brett A English; Eric Fu; Fredrik Gruenenfelder; Martina Groeschl; Karen Kimura; Wenbo Tang; Christoph von der Goltz; Corey Fowler
errShare
errSave
Valbenazine Sprinkle: An Alternative Formulation of Valbenazine for Oral Administration in Patients With Dysphagia
errCTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
err2025-11-10
err0
errOAAI
errGiri, Nagdeep; Jimenez, Roland; Rees, Linda; Mar, Alexander; Bristow, Ali; Hebert, Mello; Maynard-scott, Jessica; Zhang, Hui; Brar, Satjit
errShare
errSave
Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors
errEXPERT OPINION ON DRUG SAFETY
IF3.1
err2025-11-01
err0
PREAI
errMcIntyre, Roger S.; Karpuram, Shree; Farahmand, Khodayar; Aldrich, Kira; Bron, Morgan; Vanderhoef, Dawn; Thomas, Nina; Jacobs, Michelle; Thai-Cuarto, Dao
errShare
errSave
VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review
errCNS SPECTRUMS
IF4.1
err2025-10-22
err0
errOAAI
errPatel, Amita R.; Hauser, Robert A.; Citrome, Leslie; Bahroo, Laxman; Hicks, Tracy; Maness, Alta; Farahmand, Khodayar; Aldrich, Kira; Vanderhoef, Dawn; Cutler, Andrew J.
errShare
errSave
Inavolisib for HR-Positive, HER2-Negative Advanced Breast Cancer. Clinical Trials and Patient Access Implication
errAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
IF1.8
err2025-10-01
err1
PREAI
errArabshomali, Arman; Goswami, Swarnali; Masurkar, Prajakta P.
errShare
errSave
Optimizing glucocorticoid therapy in congenital adrenal hyperplasia and analog conditions: the intersection of dose reduction; patient care; and coverage in the US
errFrontiers in Endocrinology
IF4.6
err2025-09-10
err0
errOAAI
errAhmed Khattab; Hyunwoo Kim; Mary Mulrooney; Brian Leinwand; Nandini Hadker; Samantha Cicero; Henry Cheng
errShare
errSave
De-risking seizure liability: integrating adverse outcome pathways (AOPs), new approach methodologies (NAMs), and in silico approaches while highlighting knowledge gaps
errTOXICOLOGICAL SCIENCES
IF4.1
err2025-08-01
err0
PREAI
errBehl, Mamta; Karmaus, Agnes; Rao, Mohan; Lane, Thomas; Harris, Joshua; Sachs, Clifford; Borrel, Alexandre; Oyetade, Oluwakemi; Unnikrishnan, Aswani; Hamm, Jonathan; Hogberg, Helena T.
errShare
errSave
Reimagining Advanced Chemistry Education: A Community-based Approach to Course Design for Modern Learners
errJOURNAL OF CHEMICAL EDUCATION
IF2.9
err2025-08-01
err0
PREAI
errHorwitz, Matthew A.; Al-Ahmad, Reem; Bai, Xingfeng; Balletti, Matteo; Bellotti, Peter; Ben-Tal, Yael; Campbell, Mark W.; Cheasty, Kathleen; Crossley, Steven W. M.; Day, Craig S.; Deneny, Patrick J.; Forbes, Katherine C.; Gogarnoiu, Emma S.; Grant, Phillip S.; Halder, Riya; Harris, Georgia R.; Hernandez-Llado, Pol; Jouanneau, Morgan; Jost, Vera; Kutateladze, Dennis A.; Laudadio, Gabriele; Liu, Chun; Looby, Aidan P.; Maestro, Aitor; Mccallum, Terry; Palkowitz, Maximilian D.; Paolillo, Joshua M.; Perry, Matthew W. D.; Reisenbauer, Julia C.; Reyes, Cesar; Sharma, Hayden A.; Sheong, Fu Kit; Thoma, Benjamin; Tran, Andrew V.; Tran, Duc N.; Aguilar Troyano, Francisco Jose; Verheyen, Thomas; Walsh, Mark P.; Wagner, Alicia; Wearing, Emily R.; Wuitschik, Georg
errShare
errSave